Involvement of cytoskeleton in AhR-dependent CYP1A1 expression

Current Drug Metabolism

Volumn 7, Issue 3, 2006, Pages 301-313

  Dvorák, Zdenek ^a   Vrzal, Radim ^a   Ulrichová, Jitka ^a   Pascussi, Jean Marc ^b   Maurel, Patrick ^b   Modriansky, Martin ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

^b INSERM   (France)

Author keywords

AhR receptor; Cell cycle; Cytochrome P450; Drug metabolism; Microtubules

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON RECEPTOR; COLCHICINE; CYTOCHROME P450 1A1; MESSENGER RNA; NOCODAZOLE;

ANIMAL CELL; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL STRAIN HEPG2; CELL TYPE; CONTROLLED STUDY; CYTOSKELETON; DRUG MECHANISM; DRUG POTENCY; ENZYME ACTIVITY; ENZYME INDUCTION; FLUORESCENCE ACTIVATED CELL SORTING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LIVER CELL; MICROTUBULE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; RECEPTOR BINDING; REVIEW;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL DIVISION; CELL LINE, TUMOR; CELL SURVIVAL; CELLS, CULTURED; COLCHICINE; CYTOCHROME P-450 CYP1A1; CYTOSKELETON; FLOW CYTOMETRY; G2 PHASE; HEPATOCYTES; HUMANS; LIVER NEOPLASMS; MICROTUBULES; NOCODAZOLE; RATS; RECEPTORS, ARYL HYDROCARBON; RNA, MESSENGER; TERATOGENS; TETRACHLORODIBENZODIOXIN;

EID: 33646004897     PISSN: 13892002     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920006776359310     Document Type: Review

References (31)

1. Anzenbacher, P. and Anzenbacherova, E. (2001) Cell Mol. Life Sci. 58(5-6), 737-747.
2. Nebert, D.W., Eisen, H.J. and Hankinson, O. (1984) Biochem. Pharmacol. 33(6), 917-924.
3. Goodwin, B., Hodgson, E. and Liddle, C. (1999) Mol. Pharmacol. 56(6), 1329-1339.
4. Negishi, M., Honkakoski, M. (2000) Eur. J. Pharm. Sci. 11, 259-264.
5. Pascussi, J.M., Dvorak, Z., Gerbal-Chaloin, S., Assenat, E., Drocourt, L., Maurel, P., Vilarem, M.J. (2004) ed), Springer-Verlag. Regulation of xenobiotic detoxification by PXR, CAR, GR, VDR and SHP receptors: Consequences in physiology. In Transcription factors (Starke, K. pp. 409-435.
6. Levine-Fridman, A., Chen, L. and Elferink, C.J. (2004) Mol. Pharmacol. 65(2), 461-469.
7. Huang, G. and Elferink, C.J. (2005) Mol. Pharmacol. 67(1), 88-96.
8. Dvorak, Z., Modriansky, M., Pichard-Garcia, L., Balaguer, P., Vilarem, M.J., Ulrichova, J., Maurel, P. and Pascussi, J.M. (2003) Mol. Pharmacol. 64(1), 160-169.
9. Dvorak, Z., Maurel, P., Ulrichova, J. and Modriansky, M. (2004) Biomed. Pap. Med. Fac. Univ. Palacky. Olomouc. Czech Repub. 148(2), 135-139.
10. Dvorak, Z., Modriansky, M., Ulrichova, J., Maurel, P., Vilarem, M.J. and Pascussi, J.M. (2005) Cell Signal 17(2), 187-196.
11. Scholler, A., Hong, N.J., Bischer, P. and Reiners, J.J. Jr. (1994) Mol. Pharmacol. 45(5), 944-954.
12. Santini, R.P., Myrand, S., Elferink, C. and Reiners, J.J. Jr. (2001) J. Pharmacol. Exp. Ther. 299(2), 718-728.
13. Bonzo, J.A., Chen, S., Galijatovic, A. and Tukey, R.H. (2005) Mol. Pharmacol. 67(4), 1247-1256.
14. Moldeus, P., Hogberg, J. and Orrenius, S. (1978) Methods Enzymol. 52, 60-71.
15. Donato, M.T., Gomez-Lechon, M.J. and Castell, J.V. (1993) Anal, Biochem. 213(1), 29-33.
16. Stoscheck, C.M. (1990) Methods Enzymol. 182:50-68.
17. Schenkman, J.B. and Jansson, I. (1998) Isolation and purification of constitutive forms of microsomal cytochrome p450. in Methods in molecular biology (Phillips, I.R. and Shephard, E.A. eds), Humana Press, Totowa. pp. 55-67.
18. Laemmli, U.K (1970) Nature 227(5259), 680-685.
19. Towbin, H., Staehelin, T. and Gordon, J. (1979) Proc. Natl. Acad. Sci. USA 76(9), 4350-4354.
20. Fasco, M.J., Treanor, C.P., Spivack, S., Figge, H.L. and Kaminsky, L.S. (1995) Anal. Biochem. 224(1), 140-147.
21. Kemp, T.J., Causton, H.C. and Clerk, A. (2003) Biochem. Biophys. Res. Commun. 307(2), 416-421.
22. Herr, A.S., Wochnik, G.M., Rosenhagen, M.C., Holsboer, F. and Rein, T. (2000) Mol. Pharmacol. 57(4), 732-737.
23. Booher, R.N., Holman, P.S. and Fattaey, A. (1997) J. Biol. Chem. 272(35), 22300-22306.
24. DeFranco, D.B. (2002) Mol. Endocrinol. 16(7), 1449-1455.
25. Elbi, C., Walker, D.A., Romero, G., Sullivan, W.P., Toft, D.O., Hager, G.L. and DeFranco, D.B. (2004) Proc. Natl. Acad. Sci. USA 101(9), 2876-2881.
26. Elbi, C., Misteli, T. and Hager, G.L. (2002) Mol. Biol. Cell 13(6), 2001-2015.
27. Dvorak, Z., Ulrichova, J. and Modriansky, M. (2005) Curr. Drug Metab. 6(6), 545-552.
28. Abel, G.A., Wochnik, G.M., Ruegg, J., Rouyer, A., Holsboer, F. and Rein, T. (2002) Mol. Endocrinol. 16(6), 1352-1366.
29. Woulfe, J. and Munoz, D. (2000) Neuropathol. Appl. Neurobiol. 26(2), 161-171.
30. Schrenk, D. (1998).Biochem. Pharmacol. 55(8), 1155-1162.
31. Gouedard, C., Barouki, R. and Morel, Y. (2004) Mol. Cell Biol. 24(12), 5209-5222.